Homology Medicines, Inc.

Homology Medicines, Inc.verified

FIXX

Price:

$0.9347

Market Cap:

$3.02M

Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nuclease-free gene editing for various genetic disorders. The company's various set of AAVHSCs allows company to target, through a single injection, a range of disease-relevant tissues, including the liver, central nervous system, peripheral nervous system, bone marrow, cardiac and skeletal muscle, and eye. Its lead product candidate is HMI-102, which is in ...[Read more]

Industry

Biotechnology

IPO Date

2018-03-28

Stock Exchange

NASDAQ

Ticker

FIXX

The PE Ratio as of July 2024 (TTM) for Homology Medicines, Inc. (FIXX) is -0.03

According to Homology Medicines, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.03. This represents a change of -227.58% compared to the average of 0.02 of the last 4 quarters.

Homology Medicines, Inc. (FIXX) Historical PE Ratio (quarterly & annually)

How has FIXX PE Ratio performed in the past?

The mean historical PE Ratio of Homology Medicines, Inc. over the last ten years is 0.74. The current -0.03 PE Ratio has changed -460.80% with respect to the historical average. Over the past ten years (40 quarters), FIXX's PE Ratio was at its highest in in the March 2024 quarter at 0.23. The PE Ratio was at its lowest in in the March 2021 quarter at -11.04.

Quarterly (TTM)
Annual

Average

0.74

Median

-0.65

Minimum

-4.31

Maximum

14.97

Homology Medicines, Inc. (FIXX) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Homology Medicines, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 0%

Maximum Annual PE Ratio = 14.97

Minimum Annual Increase = -7212.14%

Minimum Annual PE Ratio = -4.31

Quarterly (TTM)
Annual
YearPE RatioChange
2023-0.03-100.21%
202214.97-7212.14%
2021-0.21-48.36%
2020-0.41-54.22%
2019-0.89-20.18%
2018-1.12-46.86%
2017-2.10-51.32%

Homology Medicines, Inc. (FIXX) Average PE Ratio

How has FIXX PE Ratio performed in the past?

The current PE Ratio of Homology Medicines, Inc. (FIXX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

4.91

5-year avg

2.69

10-year avg

0.74

Homology Medicines, Inc. (FIXX) PE Ratio vs. Peers

How is FIXX’s PE Ratio compared to its peers?

Homology Medicines, Inc.’s PE Ratio is less than Passage Bio, Inc. (0), greater than Stoke Therapeutics, Inc. (-0.61), greater than Atreca, Inc. (-5.97), greater than TCR2 Therapeutics Inc. (-0.04), greater than Adaptimmune Therapeutics plc (-0.44), greater than Black Diamond Therapeutics, Inc. (-1.85), greater than Harpoon Therapeutics, Inc. (-3.82), greater than 4D Molecular Therapeutics, Inc. (-2.94), greater than null (-8.05),

Build a custom stock screener for Homology Medicines, Inc. (FIXX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Homology Medicines, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Homology Medicines, Inc. (FIXX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Homology Medicines, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Homology Medicines, Inc.'s PE Ratio?

How is the PE Ratio calculated for Homology Medicines, Inc. (FIXX)?

What is the highest PE Ratio for Homology Medicines, Inc. (FIXX)?

What is the 3-year average PE Ratio for Homology Medicines, Inc. (FIXX)?

What is the 5-year average PE Ratio for Homology Medicines, Inc. (FIXX)?

How does the current PE Ratio for Homology Medicines, Inc. (FIXX) compare to its historical average?